SEC Tracker
Get the app

Arbutus Biopharma ABUS

Arbutus Biopharma reports ownership change

Roivant Sciences Ltd., insider filing for ABUS

Form
4
Filed
Importance
Routine
  1. Roivant Sciences Ltd. disposed of 8,967,383 common shares
  2. Transaction date: Oct 1, 2026
  3. Shares beneficially owned: 29,880,079
  4. Reporting person is a 10% owner

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Arbutus Biopharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Arvinas ARVN public float $469M, Jun 30, 2025
  2. aTYR PHARMA ATYR public float $464M, Jun 30, 2025
  3. Zevra Therapeutics ZVRA public float $455M, Jun 30, 2025
  4. Myriad Genetics MYGN public float $494M, Jun 30, 2025
  5. Kura Oncology KURA public float $496M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.